Finance

Lists
Why is CRDL down 3.78%?
Dive Deeper
CRDL:TSE
Cardiol Therapeutics Inc
CA$1.78
-3.78%
(-0.070) 1D
Oct 9, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDL...
Open
CA$1.87
High
CA$1.88
Low
CA$1.77
Mkt. cap
211.27M
Avg. vol.
297.79K
Volume
179.62K
52-wk high
CA$3.23
52-wk low
CA$1.22
EPS
-CA$0.34
Beta
0.66
Shares outstanding
116.82M
No. of employees
18
Open
CA$1.87
High
CA$1.88
Low
CA$1.77
Mkt. cap
211.27M
Avg. vol.
297.79K
Volume
179.62K
52-wk high
CA$3.23
52-wk low
CA$1.22
EPS
-CA$0.34
Beta
0.66
Shares outstanding
116.82M
No. of employees
18
News stories
From web sources and news partners
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersOakville, Ontario, Canada
SectorPharmaceutical industry
Websitecardiolrx.com
Last report
Aug 12, 2026
Fiscal period
Q2 2026
-CA$0.05 / -CA$0.10
+48.28%beat
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.79M
2.74M
4.95M
3.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.39M
5.29M
4.76M
4.74M
Operating expense
10.18M
8.03M
9.71M
7.94M
Total operating expenses
10.18M
8.03M
9.71M
7.94M
Operating income
-10.18M
-8.03M
-9.71M
-7.94M
Other non operating income
-
951.74K
-1.53M
1.35M
EBT including unusual items
-9.96M
-7.21M
-10.82M
-6.08M
EBT excluding unusual items
-9.96M
-7.21M
-10.82M
-6.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.96M
-7.21M
-10.82M
-6.08M
Net profit margin
-
-
-
-
Earnings per share
-0.12
-0.07
-0.10
-0.05
Interest and investment income
122.26K
175.21K
200.72K
201.33K
Interest expense
-
-
-
-
Net interest expenses
122.26K
175.21K
200.72K
201.33K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.17M
-8.02M
-9.70M
-7.93M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps